Moneycontrol PRO
HomeNewsIndia healthcare

India Healthcare

Jump to
  • Why not blanket GST relief for health insurance premiums?

    Tax exemptions for all will help deepen the country's insurance penetration

  • Healthcare regulation — What should be the watchdog’s mandate?

    The proposed health regulator will have to balance quality, affordability, and profitability in a public-private medical delivery system in India 

  • Hospitals' defensive credentials on display, but investment risks abound

    Hospitals have inelastic demand and pricing power. But hospitals are capital intensive businesses and expansion puts stress on financials

  • In Pics | Motorbike ambulances help moms give birth in Chhattisgarh's Narayanpur

    Motorbike ambulances are helping mothers give birth in the Naryanpur district of Chhattisgarh. Since 2014, the number of babies born in hospitals in the district has doubled to a yearly average of about 162 births from just 76 in 2014

  • Apollo Hospitals: What lends a hand to core business margins?

    The healthcare business is back on track with increase in patient visits and elective procedures. Apollo Hospitals' business margins have been impressive and the occupancy rate is likely to reach pre-COVID levels.

  • Apollo Hospitals' digital platform gives it an edge, execution key

    Apollo’s digital platform grew at a healthy pace last quarter. Its early investments are paying off and contributing to improved valuations

  • How to raise the line of defence of pharmacists in a rampaging pandemic

    With the country’s less-than-adequate health framework putting up a brave if somewhat one-sided fight, the significance of emergency preparedness & response (EP&R) in the health sector could not be more relevant than today.

  • Coronavirus pandemic: Govt agencies redeem themselves in the battle against COVID-19

    The government is at the forefront of fighting the pandemic with little sign of private medical honchos who like to wax eloquent before the electronic media on most subjects, except when it matters the most.

  • Doctors, the vanguard of COVID-19 response, face crippling shortage of protective gear

    Shortage of protective health gear in India has forced some doctors to use raincoats and motorbike helmets while fighting the coronavirus, exposing the fragile state of the public health system ahead of an anticipated surge in COVID-19 cases.

  • Coronavirus pandemic: You and I can make a positive difference; time for ISR is now

    As medics risk their lives manning patients to save lives, it is time for the citizens to rise to the challenge and shoulder responsibility.

  • A wake up call for the government on public health

    Five charts that illustrate the Indian government’s dismal record of spending on health

  • Healthcare Awards: Celebrates commitment to provide best

    India Healthcare Awards continue to recognize and celebrate the passion and commitment to provide the very best in healthcare. Watch accompanying videos for the glorious award ceremony of the India Healthcare Awards.

  • Cipla, Cadila Health, Natco Pharma top picks: AnandRathi

    AnandRathi has come out with its report on India healthcare. According to the research firm, EBITDA margins are expected to be stable at 22-23 percent during the quarter. "Cipla, Cadila Healthcare, Natco Pharma, and Unichem Laboratories are the top picks, says AnandRathi.

  • Is Indian healthcare sector in need of a makeover?

    According to World Health Organisation (WHO) an average Indian bears 76 percent of his spending on healthcare from his own pocket while in the US it is a mere 13 percent.

  • Karnataka based org tracks patients' SMSes on truant doctors

    Getting to a doctor in a city in India can be fairly simple, however in rural parts of the country, medical care can be ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347